paclitaxel has been researched along with phomoxanthone a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bickel, D; Engelke, L; Frank, M; Gohlke, H; Hamacher, A; Kassack, MU; Proksch, P; Wang, C | 1 |
1 other study(ies) available for paclitaxel and phomoxanthone a
Article | Year |
---|---|
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Caspase 3; Caspase 7; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Membrane Potential, Mitochondrial; Xanthones | 2019 |